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To determine if the cellular factors La autoantigen (La) and polypyrimidine tract-binding protein (PTB) are required for hepatitis C virus
(HCV) replication, we used siRNAs to silence these factors and then monitored their effect on HCV replication using quantitative RT-PCR. In
addition, we determined the influence of PTB on the activity of the 3V noncoding region (NCR) of HCV and investigated its interaction with
the components of the HCV replicase complex. We found that La is essential for efficient HCV replication while PTB appears to partially
repress replication. PTB does, however, block the binding of HCV RNA-dependent RNA polymerase (RdRp, NS5B) to the 3VNCR. Indirect
immunofluorescence microscopy showed co-localization of cytoplasmic PTB with the HCV RdRp in hepatoma cells (Huh-7) expressing
HCV proteins, while in vitro translation of viral proteins from the HCV replicon revealed the interaction of PTB isoforms with NS5B
polymerase and NS3.
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Hepatitis C virus (HCV) infection is a major world health
problem with a worldwide carrier rate estimated at 300
million people (Manns et al., 2001). HCV infection can
often lead to chronic hepatitis in up to 60–80% of infected
adults (Giannini and Brechot, 2003) and can then progress
to liver cirrhosis and hepatocellular carcinoma (Di Biscegli,
1997). HCV is composed of a 9.6-kb positive-sense single-
stranded RNA genome (Bartenschlager and Lohmann,
2000) and encodes a polyprotein precursor of approximately
3000 amino acids. The HCV polyprotein is synthesized on
ribosomes in the rough endoplasmic reticulum (ER) and is0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.02.009
T Corresponding author. Fax: +1 303 315 8330.
E-mail address: aleem.siddiqui@uchsc.edu (A. Siddiqui).
1 These authors contributed equally to this work.cleaved co- and post-translationally by viral and host
proteases to yield three structural proteins (core, E1, and
E2) and six nonstructural proteins (NS2 to NS5A/B)
(Bartenschlager and Lohmann, 2000; Dubuisson et al.,
2002). Many of the nonstructural proteins have been found
to be essential for productive viral replication (Kolykhalov
et al., 2000). The 5V noncoding region (5V-NCR) and the 3V-
NCR of HCV are highly conserved sequences that contain
elements that are directly involved in RNA replication (Luo
et al., 2003). The HCV 5V-NCR has been shown to function
as an internal ribosome entry site (IRES) permitting cap-
independent translation (Tsukiyama-Kohara et al., 1992;
Wang et al., 1993). The 3V-NCR has a unique non-poly (A)
tail and consists of a short variable region, a U/(UC) motif,
and a terminal 3VX tail composed of highly conserved stem-
loop structures (Kolykhalov et al., 1996).
During the initiation of HCV replication, an RNP
complex is formed at the HCV 3V-NCR of the viral genome.005) 72 – 86
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for efficient HCV replication (Blight et al., 2000; Lohmann
et al., 1999). Within the replication initiation complex there
is an RNA-dependent RNA polymerase (NS5B) that serves
as a catalytic subunit that synthesizes minus-strand RNA.
The newly synthesized negative-strand RNA then serves as
a template for the production of the plus-strand viral RNA.
Changes in intracellular events resulting from HCV
replication are poorly understood. Studying the HCV
replication processes in the context of a full-length genome
has been difficult since there are no current tissue culture or
practical animal model systems available for HCV infection.
However, the development of a selectable and efficiently
replicating HCV subgenomic replicon in a human hepatoma
cell line, Huh-7, has provided a suitable model for
investigating the mechanisms of viral persistence and
pathogenesis in the context of HCV replication (Lohmann
et al., 1999). These replicons are bicistronic constructs
composed of the HCV IRES (nucleotides 1–377 of the 5V-
NCR) directing the translation of the neomycin phospho-
transferase (neo) gene; the encephalomyocarditis IRES,
which mediates the translation of HCV nonstructural
proteins NS3 through NS5; and the 3VNCR.
The entire HCV replication cycle appears to occur in the
ER (Dubuisson et al., 2002). However, Shi et al. reported
that lipid-rafts derived from intracellular membranes could
serve as the site of HCV replication (Shi et al., 2003). This
notion is supported by the fact that the majority of the HCV
NS proteins localize to the ER and other membranous
structures (Bartenschlager and Lohmann, 2000; Dimitrova
et al., 2003; Shi et al., 2003). The ER localization of these
proteins causes severe morphological changes in the intra-
cellular membranes and induction of ER stress, a factor
responsible for activation of transcription factors that alter
cellular metabolism (Dubuisson et al., 2002; Gong et al.,
2001; Tardif et al., 2002, 2005; Waris et al., 2002). How
these metabolic changes affect the process of HCV gene
expression, persistent infection, or viral maturation have
been the subjects of intense investigations. A significant
number of studies in the recent past have focused on the
cellular and viral proteins that directly form ribonucleopro-
tein (RNP) complexes with the 5V and 3VNCRs (Ali and
Siddiqui, 1995, 1997; Ali et al., 2000; Anwar et al., 2000;
Banerjee and Dasgupta, 2001; Buratti et al., 1998; Fukushi
et al., 1997; Hahm et al., 1998; Ito and Lai, 1999;
Kolupaeva et al., 2000). Indeed, a whole host of the cellular
proteins have been shown to interact with the viral cis-
elements (Ali and Siddiqui, 1995, 1997; Buratti et al.,
1998). Chief among them are the polypyrimidine tract-
binding protein (PTB, p57 or hnRNP1) and the La antigen,
each of which have been shown to be involved in the HCV
IRES-mediated translation initiation process (Ali and
Siddiqui, 1995, 1997; Ali et al., 2000; Anwar et al., 2000;
Gosert et al., 2000).
PTB belongs to an hnRNPI family of RNA binding
proteins (Ghetti et al., 1992). It is mainly found not only inthe nucleus of cells but also shuttles to the cytoplasm. The
major function of PTB in the nucleus is to regulate the
splicing of precursor mRNAs. The protein has been shown
to facilitate translation directed by the picornavirus IRES
elements in the cytoplasm (Gosert et al., 2000). We have
previously shown that PTB interacts independently within
three separate domains of the HCV 5V-NCR, each of which
has a sequence motif that closely resembles the core of the
consensus pyrimidine tract (CYYYYCYYYYGG; Y, pyr-
imidine) (Ali and Siddiqui, 1995), with the optimal binding
site for PTB being UCUU within a pyrimidine rich context
(Perez et al., 1997). Also, by using a SELEX RNA
approach, the binding of PTB to the 5V-NCR was shown
to be required for HCV IRES function in vivo (Anwar et al.,
2000). In addition to binding to the 5V-NCR, PTB has also
been shown to bind to the 3VNCR at both the U/(UC) motif
region as well as the 3V X region (Ito et al., 1998). The
functional importance of these binding sites remains
unknown.
The La autoantigen is a highly conserved RNA-binding
phosphoprotein that is mainly associated with newly
synthesized RNA polymerase III transcripts via a binding
interaction with their UUU-OH 3V tails within the nucleus of
normal, healthy human cells (Maraia and Intine, 2001). Up
to 80% of all La protein within a cell is located in the
nucleus, but the location can vary based on different
environmental conditions within the cell permitting higher
concentrations of La to reside within the cytoplasm of the
cell as is the case during HCV transient transfections in
tissue culture cells (Izumi et al., 2004; Maraia, 2001). It has
been shown previously that La can interact with the HCV
genome at the 5V and 3VNCR regions near the initiator AUG
and within the poly U/UC region, respectively (Ali and
Siddiqui, 1997; Spangberg et al., 1999). The interaction of
La with the 5VNCR has been determined to be important for
efficient HCV translation (Ali and Siddiqui, 1997). In
addition to its role in HCV translation, La is also associated
with other IRES structures and has been found to be critical
for their function as well (Maraia and Intine, 2001).
Although the translational requirements associated with La
and its interaction with the HCV IRES have already been
characterized, the functional role of this protein in the
context of HCV replication has not been investigated.
In order to determine the effects that both La and PTB
have on HCV replication, we set out to silence both genes
and then monitor their roles in HCV replication using
quantitative RT-PCR. In this study using the subgenomic
replicon expression system we have found that La is
required for efficient HCV replication, while PTB may act
as a repressor of replication. In agreement with previous
studies our data show that both La and PTB are needed for
HCV translation (Ali et al., 2000; Anwar et al., 2000; Gosert
et al., 2000; Zhang et al., 2004). In addition, we demonstrate
direct interactions between PTB and HCV NS3 and NS5B
proteins, both of which are required for HCV replication.
These interactions may regulate the functions of the viral
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the HCV RNA genome.Results
La and PTB mRNA expression levels are diminished in
the presence of their corresponding siRNAs
To determine if La and PTB are necessary for efficient
HCV replication, we synthesized siRNA specific to La and
PTB proteins. Huh-7 cells were transiently transfected with
the HCV replicon (BM4–5) and/or siRNA against La or
PTB. Total RNA was then extracted from various cells and
subjected to quantitative RT-PCR analysis using specificFig. 1. Effects of silencing on La and PTB mRNAs. (A) Quantitative RT-PCR a
subgenomic replicon RNA (BM4–5) only or along with La siRNA (BM4–5/La
methods. RNA was harvested at 24 or 48 h post-transfection. The amount of La m
and bars represent the averages and standard deviations of three sets of duplicate r
BM4–5/La 24 h 0.02, La 24 h 0.01, BM4–5 48 h 0.88, BM4–5/La 48 h 0.0
Quantitative RT-PCR analysis of PTB mRNA. Reactions were carried out the sam
PTB mRNA was determined as described in Materials and methods. The column
duplicate reactions. P values were determine to be the following: BM4–5 24 h 0.5
48 h 0.01, and PTB 48 h 0.01. (C) Western blot analysis of La protein with La siRN
48, and 72 h post-transfection and subjected to 10% SDS–PAGE and immunoblot
antibody. The protein bands were then quantified by densitometry analysis from t
The remaining amount of protein relative to the 24-h time point is listed. ‘‘Mock’’
presence of PTB siRNA. (E) Western blot analysis of PTB protein in the presence
siRNA. All were done as stated above. The average amount La or PTB protein re
each gel. Bottom panel in each figure represents the protein loading control in wprimers and probes for both La and PTB to determine the
overall mRNA expression levels of La and PTB. Using
this approach we observed a 62% reduction of La mRNA
levels at 24 h and a 72% reduction at 48 h post-
transfection (Fig. 1A). For PTB there was about a 50%
reduction of PTB mRNA levels at 24 h and a 71%
reduction at 48 h post-transfection (Fig. 1B). Huh-7 cells
that were not transfected with either the HCV replicon
RNA, La siRNA, or PTB siRNA did not show any
decrease in either La or PTB RNA levels (Figs. 1A and
B). In addition, Western blots were done to determine the
protein levels of La and PTB during silencing. Huh-7 cells
were transfected as above and cellular lysates were
prepared as described in Materials and methods. We
observed modest reductions in both La and PTB proteinnalysis of La mRNA. Huh-7 cells were transiently transfected with HCV
) or La siRNA only (La) or neither (mock) as described in Materials and
RNAwas determined as described in Materials and methods. The columns
eactions. P values were determined to be the following: BM4–5 24 h 0.89,
3, and La 48 h 0.02. Significant P values are values less than 0.05. (B)
e as above except using PTB siRNA during the transfection. The amount of
s and bars represent the averages and standard deviations of three sets of
7, BM4–5/PTB 24 h 0.08, PTB 24 h 0.03, BM4–5 48 h 0.44, BM4–5/PTB
A. Huh-7 cells were transfected as above. Total protein was extracted at 24,
ted as described in Materials and methods. The blot was probed with anti-La
hree sets of transfection experiments each normalized to the levels of actin.
samples had no La siRNA. (D) Western blot analysis of PTB protein in the
of La siRNA. (F) Western blot analysis of La protein in the presence of PTB
maining from three data sets relative to the 24-h time points is listed below
hich lysates were immunoblotted with anti-actin antibody.
Fig. 2. Effects of La and PTB silencing on HCV IRES translation (A)
Western blot analysis of neomycin with La siRNA. Huh-7 cells were
transfected. Total protein was extracted at 24 or 48 h post-transfection and
then run on a 12% SDS–PAGE gel and immunoblotted. The blot was
probed with an anti-neomycin phosphotransferase antibody followed by a
monoclonal anti-actin antibody. The columns and bars of the graph
represent the averages and standard deviations of the densitometry analysis
from three sets of transfection experiments each normalized to the levels of
actin. (B) Western blot analysis of neomycin with PTB siRNA at 24, 48,
and 72 h post-transfection. The blots and graph were done as stated above
and also represent data from three sets of transfection experiments.
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and D). This modest reduction of La and PTB proteins
probably reflects the abundance of these proteins in Huh-7
cells. We next determined that the effects of siRNAs on
these proteins were specific. As shown in Figs. 1E and F, in
the presence of La siRNA, PTB protein levels were not
diminished and, similarly, La protein levels were not
reduced in the presence of PTB siRNA.
HCV IRES translation decreases when La or PTB is
silenced
Using RNA SELEX technique, we have previously
shown that La and PTB are required for HCV IRES
function (Anwar et al., 2000). In a recent study, results
showing that La is necessary for HCV IRES function
were reported using La siRNA (Costa-Mattioli et al.,
2004). Here, we have undertaken an siRNA approach to
establish the role of La and PTB on HCV translation and
replication using the subgenomic replicon expression
system. Huh-7 cells were transfected with the HCV
subgenomic replicon (BM4–5) and/or La siRNA or
PTB siRNA. Cellular lysates were prepared as described
in Materials and methods. Western blot analysis was used
to monitor neomycin protein levels, which are under the
translational control of the HCV IRES. La siRNA caused a
46% decrease in neomycin protein levels at 24 h and a 58%
reduction at 48 h (Fig. 2A). For PTB, we found that there
was a 50% reduction of neomycin protein levels at 24 h and
a 69% and 86% reduction at 48 h and 72 h, respectively
(Fig. 2B). As expected, we did not see neomycin protein
expression in the Huh-7 cells that were only transfected with
La siRNA/PTB siRNA or in the Huh-7 cells that were not
transfected with La siRNA/PTB siRNA and BM4–5 RNA
since these cells do not contain the neomycin gene. In a
previous study by Zhang et al., siRNA against PTB and La
in the context of a bicistronic HCV replicon similar to the
one used in this paper had no affect on EMCV IRES
translation, indicating that the changes in neomycin levels
that we detected are a result of decreased HCV IRES
activity uncoupled from EMCV IRES translation (Zhang et
al., 2004).
La is required for HCV subgenomic replication
Next, we determined the effects of La siRNA on HCV
replication. As shown above, the La siRNA is efficient at
reducing the amount of La mRNA being produced by the
cell. Here we show that in the presence of La siRNA there is
a reduction in the HCV subgenomic RNA replication. By
using quantitative RT-PCR, we observed a significant
reduction of HCV replication activity. Huh-7 cells cotrans-
fected with replicon RNA and La siRNA displayed a 63%
and 67% reduction at 24 and 48 h post-transfection,
respectively (Fig. 3A). These results indicate that La is
required for efficient HCV subgenomic replication.PTB effect on HCV replication
Again by using quantitative RT-PCR, we analyzed the
effect of PTB siRNA on HCV replication. We found that
even though PTB mRNA expression levels were decreased
to 50% and 71% at 24 and 48 h, respectively (Fig. 1B), we
observed a 45% reduction of HCV replicon RNA at 24 h
and only a modest 6% reduction at 48 h (Fig. 3B). We then
further investigated the role of PTB using subgenomic
Fig. 3. Effect of La siRNA on BM4–5 replication. (A) Quantitative RT-PCR analysis of subgenomic replicon RNA (BM4–5) in the presence of La siRNA.
The reactions were carried out as stated in Fig. 1 except the levels of BM4–5 mRNA and 18S rRNAwere detected and the mRNA levels of BM4–5/La were
normalized to the levels of BM4–5 mRNA. P values were determined to be the following: BM4–5/La 24 h 0.04 and BM45/La 48 h 0.04. (B) Quantitative RT-
PCR analysis of subgenomic replicon RNA (BM4–5) in the presence of PTB siRNA. Same as above except using PTB siRNA. P values were determined to be
the following: BM4–5/PTB 24 h 0.05 and BM4–5/PTB 48 h 0.69. (C) Quantitative RT-PCR analysis of subgenomic replicon RNA (BM4–5) in the presence
of PTB siRNA using RNA from the translation defective mutant, 233. Same as above expect RNA from the 233 mutant was used in place of the BM4–5 RNA
and the levels of 233/PTB were normalized to the levels of 233 mRNA. P values were determined to be the following: 233/PTB 24 h 0.8228 and 233/PTB 48 h
0.0474. (D) Quantitative RT-PCR analysis of PTB mRNA in the presence and absence of 233 RNA. Reactions were carried out as described in Fig. 1. P values
were determined to be the following: 233 24 h 0.6857, 233 48 h 0.9709, 233/PTB 24 h 0.0001, and 233/PTB 48 h 0.0112.
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inactivated by mutagenesis. Mutant 233 has mutations in
the stem-loop IIIc of the HCV IRES starting at nucleotide
233 and is shown to inhibit the ability for the HCV IRES to
perform its role in translation initiation (Fig. 4). When this
mutant was transfected into Huh-7 cells we observed an
increase of HCV replicon RNA at 48 h in the presence of
PTB-specific siRNA (Figs. 3C and D). Together, these
results suggest that PTB may not be required for HCV
replication.
PTB competes with HCV NS5B on the 3VNCR
We set out to further investigate the role of PTB in HCV
replication by focusing on the interactions of PTB with
HCV nonstructural proteins. The interaction of NS5B with
the 3VNCR is considered a critical step during the replicationinitiation process. Interestingly, PTB binds cis-elements
within the 3VNCR that are located in the vicinity of the
NS5B-binding site (Ito et al., 1998; Tsuchihara et al., 1997).
Therefore, it is likely that binding of PTB to these regulatory
elements may affect the replicase function during the
initiation of replication. To address this issue, recombinant
NS5B that is capable of replicating full-length HCV RNA in
vitro (Oh et al., 1999) was UV cross-linked with a
radiolabeled 3VNCR probe and subjected to SDS–PAGE
followed by autoradiography. The appearance of a radio-
labeled protein band indicates binding of NS5B to the
3VNCR (Fig. 5A, lane 2). In similar reactions, increasing
amounts of GST-PTB (lanes 3–6) or GST (lane 7) were
added during the UV cross-linking assay. The binding of
NS5B to the 3VNCR gradually decreased with increasing
amounts of PTB. However, a 10- to 20-fold molar excess of
NS5B exhibited a low level of interaction with the 3VNCR
Fig. 4. Effect of 233 mutant on HCV IRES translation. (A) Western blot analysis of neomycin with 233 RNA. Huh-7 cells were transiently transfected via
electroporation with the HCV IRES translation defective BM4–5 subgenomic replicon mutant, 233, as described in Materials and methods. Total protein was
extracted at 6, 48, and 96 h post-transfection and then subjected to 12% SDS–PAGE gel and immunoblotted with anti-neomycin phosphotransferase antibody
followed by a monoclonal anti-actin antibody. (B) HCV IRES with 233 mutation indicated in the boxed area (HC233).
A.M. Domitrovich et al. / Virology 335 (2005) 72–86 77under these conditions (lanes 4–5). The NS5B–3VNCR
interaction was modestly affected by the GST control which
is not uncommon in GST pull-down assays and does not
impact our overall results (lane 7). These results demon-
strate that GST-PTB but not GST, interferes with the
interaction of NS5B polymerase with the 3VNCR.
In addition to the 3VNCR, HCV polymerase also interacts
with the 3V terminal region of the negative-strand RNA
intermediate for plus strand synthesis. This region is
complementary to the 5VNCR and is represented here as
()5VNCR RNA. Using a ()5VNCR probe in a UV cross-
linking assay as described above, we further investigated
whether PTB affects the binding of NS5B to this sequence
(Fig. 5B). Neither GST-PTB (lanes 3–6) nor GST alone
(lane 7) affected the interaction between NS5B and
()5VNCR. Based on these results, we conclude that the
interaction between PTB and 3VNCR may influence the
ability of NS5B to bind this region in the replication
initiation step. It is also possible that the observed inhibitionmay result from direct protein–protein interactions between
PTB and NS5B as described below.
HCV RNA polymerase co-localizes with cytoplasmic PTB
Huh-7 cells were transiently transfected with a pCMV/
729-3010 vector that expresses all the HCV NS proteins
(NS2 through NS5B) under the control of the CMV
promoter (Hijikata et al., 1993). The transfected cells were
subjected to indirect immunofluorescence microscopy using
polyclonal anti-PTB and monoclonal anti-NS5B antibodies
(Fig. 6A). The transfected cells expressing the NS proteins
showed cytoplasmic punctate staining of NS5B (marked as
Fa_) as previously reported (Shi et al., 2003). Although PTB
is predominantly found in the nucleus (Back et al., 2002;
Perez et al., 1997) (cells indicated as Fb_, also see PTB
staining in Fig. 6B, panel b), the transfected cells (panel a,
indicated with an arrow) exhibited cytoplasmic localization
of PTB. The expression pattern was similar to that of NS5B
Fig. 5. Competition of PTB with NS5B for the HCV promoters. (A) Competition for 3VNCR. The in vitro synthesized 32P-labeled 3VNCR was UV cross-linked
with the bacterially expressed NS5B (lane 2). In similar reactions, indicated amounts of GST-PTB (lanes 3–6) or GST (lane 7) were added. The UV cross-
linked products were analyzed by SDS–PAGE and autoradiography. The experiment was repeated three times and a representative result is shown here. The
individual PTB and NS5B bands in the mixtures were identified and characterized in separate experiments (not shown). Lane 1, control without protein; lane
M, 14C-labeled marker proteins. The molar concentration of PTB and NS5B was calculated in each sample and presented as a molar ratio of NS5B to PTB (on
bottom of the figure). (B) Competition for the ()5VNCR. UV cross-linking was carried out with a ()5VNCR probe and analyzed as described above.
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c). We further explored the possibility of the cytoplasmic
localization of PTB in cells that were transiently transfected
with the in vitro transcribed HCV subgenomic BB7 and
BB7 Pol replicon RNAs (Blight et al., 2000). Both RNAs
express NS proteins in the cells (Fig. 6B, panel a, indicated
with arrow). However, in contrast to BB7, which efficientlyFig. 6. Indirect immunofluorescence microscopy for the localization of NS5B and
with the plasmid pCMV/720–3010 for 48 h and double-stained with monoclonal a
NS5B, (b) example of untransfected Huh-7 cells. (B) Huh-7 cells were transfected w
e–h) RNAs and the cells were stained as above. The immunofluorescence of PT
indicate the Huh-7 cell expressing NS5B. Arrows in panel b indicate staining
bis-benzimide.replicates in Huh-7 cells, the BB7 Pol is replication-
defective due to a mutation in the GDD motif of NS5B. In
both cases, PTB and NS5B were co-localized in the
cytoplasm (panel c). Together, these results demonstrate
an interaction between PTB and the NS5B polymerase, and
indicate that the catalytic activity of NS5B polymerase may
not be required for this interaction.PTB in Huh-7 cells expressing HCV proteins. (A) Huh-7 cells transfected
nti-NS5B antibody and polyclonal anti-PTB antibodies. (a) Cells expressing
ith 5 Ag each of in vitro transcribed BB7 (panels a–d) or BB7 Pol (panels
B and NS5B was detected using appropriate antibodies. Arrows (panel a)
of PTB in the nucleus of untransfected cells. Dapi, nuclear staining with
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To further investigate the interaction between PTB and
HCV NS proteins, the HCV NS5B gene was transcribed in
vitro from pEMCV-5B and translated in rabbit reticulocyte
lysates. The translation of NS5B protein was confirmed by
radiolabeling with 35S-methionine and analyzed by SDS–
PAGE. The radiolabeled NS5B was allowed to interact with
GST, GST-PTB, and GST-La proteins that were immobi-
lized on glutathione-Sepharose beads (Fig. 7A). To one of
the reaction mixtures, RNase A was added to show that the
template RNA present in the translation lysate did not
mediate these interactions. The binding of NS5B polymer-
ase to GST-PTB in the RNase treated (lane 4) or untreated
(lane 3) lysates was detected, whereas the GST control did
not show any binding (lane 1). The GST-La protein also
failed to exhibit any appreciable interaction with NS5B
under similar conditions (lane 2). These results indicate that
NS5B may directly interact with PTB via protein–protein
interaction. This novel interaction was further investigated
in the presence of other nonstructural (NS) proteins that
form complexes with NS5B in vivo. The in vitro transcribed
BB7 subgenomic replicon was translated in a HeLa S10
translation system (Barton et al., 1996). The polyprotein
processing and translation products were verified by 35S-
methionine labeling of the proteins followed by SDS–
PAGE and autoradiography (data not shown). In parallel
reactions, the unlabeled viral NS proteins were translated
and subjected to immunoprecipitation with antibodies
against NS5B, NS3, and human La protein in the presence
of excess amount of RNase A. PTB binding was sub-
sequently detected by Western blot analysis of the gel using
a monoclonal anti-PTB antibody (Fig. 7B). Both NS5B
(lane 2) and NS3 (lane 3) were found to interact with PTB
present in HeLa cytoplasmic lysates. Interestingly, the
mobility of the PTB bands in both lanes was slightly
different. PTB has been shown to exist in three alternatively
spliced isoforms (PTB-1, PTB-2, and PTB-4). PTB-2 andFig. 7. Interaction of PTB with NS5B and NS3 in vitro. (A) Interaction of in vitro
NS5B in the presence of 35S-methionine and subjected to a GST-pull down assay as
the lysate was treated with RNase A (20 Ag) after translation was completed. M, m
cell-free lysates and immunoprecipitated with antibodies against NS3 (lane 3), NS5
immunocomplexes were immobilized on Protein G-Sepharose beads and subjectePTB-4 isoforms differ from PTB-1 by an insertion of 19 and
26 amino acids in the middle region of the protein
respectively (Wagner and Garcia-Blanco, 2001; Wollerton
et al., 2001). Because of this property, two closely migrating
PTB bands are usually detected in HeLa lysates (Ali and
Siddiqui, 1995). In the present analysis, we observed a
slight shift in the mobility of PTB, reflecting the possibility
that different isoforms of PTB maybe causing the difference
in mobility.
Interaction of PTB with replication proteins in the cell-free
replication system
We have recently developed a cell-free HCV replication
system that utilizes cytoplasmic lysates prepared from Huh-
7 cells harboring the HCV subgenomic replicon (designated
as FCA4) (Ali et al., 2002). The FCA4 lysates prepared by
gentle lysis from Huh-7 cells which stably express the HCV
replicon (Guo et al., 2001) were shown to contain preformed
ribonucleoprotein complexes that actively replicate the
endogenous replicon RNA templates (Ali et al., 2002). We
utilized the FCA4 cell-free replication lysates to investigate
PTB interaction with the replicase complex. The integrity of
the complex was determined by the presence of intact NS5A
and NS5B proteins in the FCA4 lysate preparations using a
Western blot assay (Fig. 8A). The cell-free lysates derived
from the parent Huh-7 cells showed no cross-reactivity with
the antisera used in the Western blot analysis. Both FCA4
and Huh-7 lysates were treated with a large excess of RNase
A and subjected to immunoprecipitation using antisera
against NS3 and NS5B proteins. The liquid immunopreci-
pitates were fractionated by SDS–PAGE and immunoblot-
ted with an anti-PTB antibody. The interactions of both NS3
as well as NS5B with PTB were detected in FCA4 lysates
(Fig. 8B, lanes 1 and 3) but not in control samples (Fig. 8B,
lanes 2 and 4). These results confirm that PTB physically
interacts with the HCV proteins in vivo in the context of the
RNP complex. However, we cannot rule out the possibilitylabeled NS5B with PTB. An EMCV-NS5B template was used to translate
described in Materials and methods. Lane 4 is identical to lane 3 except that
olecular weight marker. (B) The BB7 replicon RNAwas translated in HeLa
B (lane 2), normal human serum (lane 1), and anti-La antigen (lane 4). The
d to Western blot analysis. The blot was probed for PTB.
Fig. 8. Interaction of cellular PTB with the HCV NS proteins. (A) Western
blot for the detection of viral proteins in FCA4 lysates. The cell-free HCV
replication lysate (FCA4) was subjected to direct Western blot analysis to
confirm the presence of intact NS5B proteins. Similar Huh-7 lysates served
as a control. The blot was probed with antibodies that identify NS5A and
NS5B proteins. (B) Binding of cellular PTB with the HCV NS3 and NS5B.
Immunoprecipitation (IP) was performed using RNase A-treated FCA4
replication lysates (lanes 1 and 3) or Huh-7 cells (lanes 2 and 4) with
polyclonal anti-NS5B and monoclonal anti-NS3 antibodies as indicated.
The samples were fractionated on 10% SDS–PAGE and electrophoretically
transferred to nitrocellulose membranes. The blot was probed with a
monoclonal antibody against PTB.
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mixtures.Discussion
In order for both HCV translation and replication to occur,
one of these processes must be blocked to allow the other
process to take place since they occur in opposite directions.
Cellular factors that have previously been shown to bind to
the 5V and 3VNCRs of HCV have been proposed to play
pivotal roles in translation and replication. In this study, we
have used transient transfections of Huh-7 cells with siRNA
oligonucleotides specific to two such factors PTB and La to
determine if silencing of these factors affects both translation
and replication. We found that in the case of La, both
translation and replication levels were decreased. However,
with PTB, translation levels were reduced while replication
levels were moderately enhanced in the presence of siRNA.
In addition, we provide evidence for interactions between
PTB and two viral NS proteins (NS3 and NS5B) that are
required for HCV replication (Bartenschlager and Lohmann,
2000; Ikeda et al., 2002; Pause et al., 2003; Pietschmann et
al., 2002). Further, we also showed that PTB competes with
the NS5B polymerase for binding to the 3VNCR.
La, a 52-kDa autoantigen, was one of the first cellular
proteins identified to interact with IRES elements and to
stimulate HCV IRES-mediated translation (Dasgupta et al.,2004; Maraia and Intine, 2001). In this study, we have found
that in addition to interacting with the HCV IRES to initiate
translation, La also serves as a required cellular factor
necessary for efficient HCV replication. It has previously
been shown that the La protein interacts with the HCV IRES
within the stem-loop IVof the HCV 5VNCR in the context of
the initiator AUG codon (Ali and Siddiqui, 1997). In addition
to this interaction, La protein can also interact and change the
conformation of the large ribosomal subunit protein S5 (Pudi
et al., 2004). In light of these findings, it is possible that the
La protein could be required to assist in the unwinding of the
RNA within stem-loop IV of the HCV 5VNCR to allow the
initiator AUG accessible for processing by the mature
ribosomal complex in order to start translation of the HCV
polyprotein. By helping to bring together the mature
ribosomal complex to engage in translation, we hypothesize
that La could guide the movement of the ribosomal complex
in the 5VNCR and beyond. Previous work has shown that
stem-loops I and II are required for HCV replication and that
stem-loops II through IV are required for translation (Pudi et
al., 2003; Qi et al., 2003). These data suggest a dual role for
the sequences located within stem-loop II of the HCV
5VNCR. This dual role could play a part in the molecular
switch between viral translation and replication by selec-
tively binding to different host and/or viral factors during
different phases of the viral life cycle. It is also known that
during translation stem-loop II makes extensive contacts
with the 40S ribosomal subunit (Spahn et al., 2001).
PTB has been shown to interact with multiple pyrimidine
tracts in the HCV genome that are found in the 5V-NCR, the
core protein coding region, and within the 3V-NCR including
the 3VX region (Ali and Siddiqui, 1995; Anwar et al., 2000;
Ito and Lai, 1999; Ito et al., 1998; Tardif et al., 2002). In many
instances these interactions have been found to be required
for the regulation of HCV IRES function. In this study, we
have provided evidence that PTB does play an active role in
HCV IRES translation acting as an enhancer. However, PTB
appears to impart negative constraints on HCV replication.
This, most probably, is medicated via its interaction with the
3VNCR and nonstructural proteins (NS3 and NS5B).
When we transiently cotransfected Huh-7 cells with both
HCV subgenomic RNA and PTB siRNA, we saw an initial
lag in RNA replication (Fig. 3B, 24 h) followed by an
increase in RNA replication levels close to the levels of cells
that were only transfected with HCV subgenomic RNA at
48 h post-transfection (Fig. 3B, 48 h). In addition, when a
translationally defective mutant 233 was used, there was a
1.5- to 2-fold increase in HCV RNA replication at 48 h post-
transfection in the absence of PTB (Fig. 3C). It has
previously been determined that PTB binds to stem-loops
I and II of 3VX in the 3VNCR (Chung and Kaplan, 1999). It
has further been shown that deletions of either stem-loops I
or II within the 3VX region are detrimental for HCV
replication (Frieb and Bartenschlager, 2002).
The binding of PTB to both 5V and 3V cis-elements within
the NCRs may help to block the initiation of replication
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IRES while preventing NS5B from binding to the 3VNCR
needed for the assembly of the replication initiation
complex. It seems possible that once a threshold level of
viral proteins is synthesized, NS5B and NS3 proteins may
physically engage PTB. This engagement will diminish
PTB’s ability to enhance the HCV IRES function. By the
same token, such interactions may also relieve the inhibitory
effect of PTB on NS5B–3VNCR interactions, resulting in the
overall regulation of both translation and initiation of
replication processes. This hypothesis is partially supported
by the quantitative evaluation of the competition data
presented in Fig. 5A. It seems possible that an excess of
NS5B may alleviate the PTB inhibition. For example, a 10-
to 20-fold molar excess of NS5B showed a significant
amount of 3VNCR binding in the presence of PTB. Recent
studies suggest that oligomerization of NS5B is required for
efficient HCV replication (Qin et al., 2002). In this respect,
the oligomerization of NS5B may increase the local
concentration of NS5B in the vicinity of the 3VNCR, thus
overcoming the PTB inhibitory effect on the ability of the
polymerase to bind to the 3VNCR. In fact, poliovirus RdRp,
which is similar to HCV NS5B (RdRp) in many respects,
has been shown to form sheet and tube-like structures
resulting from oligomerization and these structures are also
known to be critical for poliovirus replication (Lyle et al.,
2002).
PTB predominantly resides in the nucleus but trans-
locates to the cytoplasm under certain conditions (Back et
al., 2002; Perez et al., 1997; Zang et al., 2001). Using an
indirect immunofluorescence procedure, we show that PTB
is localized in the cytoplasm of Huh-7 cells expressing HCV
proteins and those harboring subgenomic replicon RNAs
(Fig. 6). The subgenomic RNA that transiently transfected
cells similarly displayed cytoplasmic distribution of PTB. It
should be noted that replication defective subgenomic (BB7
Pol) RNA can only translate the viral proteins but is
crippled in its ability to replicate due to GDD mutations in
NS5B. Nonetheless, cytoplasmic staining of PTB was
clearly evident in both cases. This implies that the viral
protein expression or events such as formation/assembly of
HCV ribonucleoprotein complexes may be sufficient to
trigger similar redistribution of PTB in the cells as seen with
wild-type HCV RNA.
The IRES elements of HCV and picornaviruses recruit
translation initiation factors and nuclear proteins such as La
antigen and PTB (Hellen and Sarnow, 2001; Sarnow, 2003).
It has been hypothesized that Fcross-communication_
between the 5V and 3V ends of mRNA plays a critical role
during cap-dependent and picornavirus IRES-mediated
translation. This communication is established by a pro-
tein-bridge formed between the translation factor eIF-4G
and poly (A) binding protein (PABP) in an RNP super-
complex [i.e., Cap/IRES-(eIF-4G)-PABP-(polyA)] (Sachs et
al., 1997). In the case of HCV, since it contains a unique
3VNCR, it is possible that both PTB and/or La protein maybe engaged in 5V and 3V cross communication. At present,
there is no evidence for any such interactions. Further
investigations are needed to examine these interactions.Materials and methods
Cell culture
Huh-7 human hepatoma cells were cultured in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 100 U of penicillin/ml, and
100 Ag of streptomycin sulfate/ml. Cells were maintained at
5% CO2 and 37 -C.
Plasmids and in vitro RNA transcription
The plasmid containing the HCV subgenomic replicon
BM4–5 was obtained through a generous gift from C.
Seeger (Fox Chase Cancer Center). The BM4–5 plasmid
contains within it a bicistronic, subgenomic HCV replicon
that can be transcribed in vitro from a T7 promoter using
DNA linearized by ScaI. This replicon consists of the HCV-
IRES (nucleotides 1–377 of the 5VHCV NCR) directing the
translation of the neomycin phosphotransferase (neo) gene
and the encephalomyocarditis (EMCV) IRES directing the
translation of the HCV nonstructural proteins NS3 through
NS5B, followed by the HCV 3VNCR.
HCV replicon RNA was transcribed in vitro from linear
BM4–5 DNA cut by the ScaI restriction enzyme. RNAwas
synthesized using the Ampliscribe T7 transcription kit
(Eppicentre) according to the manufacturer’s protocol. The
quantity of the RNAwas assessed by spectrophotometer and
the quality was checked visually on a 1% TBE gel.
The plasmids pNCR-C(AUG) and p3VNCR encode the
HCV IRES (nt 1–356 of HCV-1a) and the 3VNCR (HCV-1b)
respectively under the control of T7 promoter. The plasmid
pEMCV-5B encodes an RNA that contains the HCV NS5B
gene between the upstream EMCV IRES and the down-
stream HCV 3VNCR. These HCV sequences were cloned into
the vector pGEM-4 (Promega). The plasmid encoding the
HCV replicon BB7 construct and a corresponding replica-
tion-deficient BB7 mutant (BB7 Pol) construct was a
generous gift from Dr. C. M. Rice (Blight et al., 2000). The
plasmid pCMV/720–3010 encodes HCV 720–3010 amino
acids of the genotype 1b (Hijikata et al., 1993).
The plasmids pNCR-C(AUG) and p3VNCR were line-
arized with EcoRI whereas pEMCV-5B, pBB7, and pBB7
Pol were linearized with ScaI. The linear DNAs were
eluted from agarose gels and transcribed with T7 RNA
polymerase using AmpliScribe T7 transcription kit (Epi-
center Technologies) according to the manufacturer’s
instruction. To synthesize the complementary strand of the
HCV IRES [()5VNCR], the NCR-C(AUG) plasmid was
linearized with HindIII and transcribed with SP6 polymer-
ase as described above.
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The BM4–5 plasmid was used as the wild-type template
that the site-directed mutation was constructed from
(nucleotides 233–236 in HCV IRES region). Site-directed
mutagenesis reactions were carried out using the PfuTurbo
DNA Polymerase PCR system (Stratagene) according to the
manufacturer. Following the PCR reaction, the PCR
products were digested with DpnI (Promega). The Escher-
ichia coli strain DH5 alpha was then transformed by
electroporation with the digested PCR product using stand-
ard procedures. Mutations were confirmed by DNA
sequence analysis. 1 Ag of in vitro transcribed RNA from
the HCV 233 construct was electroporated into 4  106
Huh-7 cells as described by Lohmann et al. (2003).
La siRNA cotransfection with bicistronic HCV replicon
siRNA targeted against La autoantigen mRNA was
created using the oligonucleotides below. The procedure
for generating siRNA using a T7 primer system has been
described previously (Donze and Picard, 2002). The
sequences for generating the siRNAs are as follows: T7
primer, 5V-TAATACGACTCACTATAG-3V; La siRNA sense
primer, 5V-ATGTCTCTACAAATTTCTTAGCTATAGT-
GAGTCGTATTA-3V; and the La siRNA antisense primer,
5 V-CTGCTAAGAAATTTGTAGAGACTATAGTGA
GTCGTATTA-3V. One day prior to cotransfection, Huh-7
cells were trypsinized and resuspended in complete DMEM
and plated onto 6-cm plates at approximately 30%
confluency. Cotransfection experiments were performed
using Lipofectamine 2000 (Invitrogen). For each trans-
fection two solutions were made, A and B. Solution A: 500
pmol of La siRNA, 10 Ag of HCV replicon RNA, or both,
were added to 100 Al of OPTIMEM media (Invitrogen).
Solution B: 6 Al of Lipofectamine 2000 was added to 100
Al OPTIMEM media. Solutions A and B were allowed to
incubate at room temperature for 15 min. After 15 min,
solutions A and B were combined, gently mixed, and
allowed to incubate another 20 min at room temperature.
The combined solutions were then added to the cells in
the 6-cm plates. The cells were then incubated for 4 h at
37 -C and 5% CO2. After 4 h, the transfection solution
was replaced with 3 mL of complete DMEM growth
media.
PTB siRNA cotransfection
The day before the transfection, Huh-7 cells were
trypsinized and resuspended in complete DMEM and then
seeded at 9  104 cells in 24-well dishes. Cotransfection
experiments were performed as above with the following
changes: 50 pmol of PTB siRNA (Dharmacon, SMART-
pool) and 0.5 Ag of HCV replicon RNAwere added to 50 Al
of OPTIMEM media. In addition, solutions A and B were
allowed to incubate for 5 min separately before beingcombined. The transfection solution was replaced with
DMEM after 24 h of incubation.
Western blotting
Total protein was obtained at 24 and 48 h post-trans-
fection (and 72 h for PTB). For the 233 mutant, protein
samples were taken at 6, 48, and 96 h post-transfection.
Growth media were removed from the transfected Huh-7
cells and the cells were washed once with PBS-EDTA. Cells
were then allowed to incubate at room temperature in PBS-
EDTA for 20 min. Cells were then removed from the plates
and centrifuged at 4 -C. Total protein was harvested using
the corresponding lysis buffers: for La and 233 proteins, 10
mM HEPES-KOH [pH 7.2], 140 mM KCl, 5 mM MgCl2, 1
mM EGTA, 1% NP-40, 1 protease inhibitor cocktail
[Roche] and for PTB the lysis buffer was the same with
the following changes: 5 mM KCl and 1 mM EDTA instead
of EGTA. Cell pellets were resuspended in 50–100 Al of
lysis buffer and were allowed to incubate on ice for 25 min.
The resuspended cells were then centrifuged for 10 min at
4 -C. The supernatant was run on a 12% SDS–PAGE gel and
transferred to a nitrocellulose membrane (BioRad, Trans-
Blot Transfer Medium) at 100 V for 90 min at 4 -C. The
membranes were probed and developed using SuperSignal
West Dura Extended Duration Substrate (Pierce). Images
were captured on the Kodak 440CF Imaging System. The
band intensities from the Western Blots were measured with
1D Image Analysis Software from Kodak. La protein was
probed using the monoclonal anti-La antibody (SW5). PTB
protein was detected with a polyclonal anti-hnRNPI anti-
body (Santa Cruz Biotechnologies). The polyclonal anti-
neomycin phosphotransferase antibody was obtained from
Cortex Biochem. The monoclonal anti-Actin antibody was
purchased from NeoMarkers (Fremont, CA.).
Quantitative RT-PCR
Total RNAwas harvested at 24 and 48 h post-transfection
using RNA-STAT60 (Tel-Test), following the manufactur-
er’s standard procedures. RNAwas quantified using an ABI
PRISM 7000 Sequence Detection System (Applied Bio-
systems). Quantification runs were done in duplicate.
Amplifications were conducted using the following primers
and dual-labeled probes (Qiagen): La mRNA probe, 5V-
6FAM-TAC GGC TAT CTT TAA GGT TCC GGC CCA-
TAMRA-3V; La mRNA forward primer, 5V-CTG TGG CGC
GGC TTC T-3V; La mRNA reverse primer, 5V-TCC AGG
GCA GCC ATC TTT T-3V; PTB mRNA probe, 5V-6FAM-
CAC CAG ATT TTC TCC AAG TTC GGC ACA-
TAMRA-3V; PTB mRNA forward primer, 5V-ACC CTG
TGA CCC TGG ATG TG-3V; PTB mRNA reverse primer,
5V-TGT TCT TGG TGA AGG TGA TGA TCT-3V; HCV
Replicon probe, 5V-6FAM-CCT TCA TCT CCT TGA GCA
CGT CCC G-TAMRA-3V; HCV replicon forward primer, 5V-
CTT TGA CAG ACT GCA GGT CCT G-3V; HCV replicon
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18S rRNA probe, 5V-6FAM-TGC TGG CAC CAG ACT
TGC CCT C-TAMRA-3V; 18S rRNA forward primer, 5V-
CGG CTA CCA CAT CCA AGG AA-3V; 18S rRNA reverse
primer, 5V-GCT GGA ATT ACC GCG GCT-3V. The
sequences for the primers and probes were designed on
Primer Express software (Applied Biosystems). Amplifica-
tion reactions were performed in a 25-Al reaction mix using
the Quantitect RT PCR kit (Qiagen) containing a final
concentration of each primer at 0.5 AM, and each probe at
0.2 AM. For the quantification reactions using the La
mRNA primer/probe set, the PTB mRNA primer/probe set
and the HCV replicon primer/probe set the total RNA input
amount were 250 ng. For the quantification reaction using
the 18S rRNA primer/probe set, the total RNA input
amount was 250 pg. Reactions were performed under the
following conditions: 30 min at 50 -C (reverse tran-
scription reaction); 15 min at 95 -C (heat inactivation of
the reverse transcriptase and activation of the Taq polymer-
ase); 35–40 cycles of 15 s at 95 -C and 1 min at 60 -C
(PCR amplification and data acquisition). The results from
each run were calculated using the comparative DDCt
method as described in the ABI Prism 7000 handbook
(appliedbiosystems.com, user bulletin #2: ‘‘Relative Quan-
tification of Gene Expression,’’ part #4303859B). All
experimental results were normalized to the 18S rRNA
endogenous control. Each normalized result was then used
to compare differences within various experimental con-
trols such as mock for the silencing experiments and
BM4–5 when compared to BM4–5 cotransfected with
siRNA. Graphed results are the averages of three separate
duplicate runs analyzed in the manner described above.
Two-tailed P values were determined by performing a
paired t test calculated using the statistical program
‘‘GraphPad InStat’’ version 3.06, GraphPad Software, San
Diego, CA, www.graphpad.com.
Expression and purification of recombinant proteins
The plasmid GST-2TK/PTB, which encodes the gluta-
thione S-transferase (GST)-human PTB fusion protein, was
a generous gift from Dr M. A. Garcia-Blanco. The
expression of GST-PTB was induced with 1 mM IPTG in
E. coli (JM101) and affinity-purified on glutathione-
Sepharose beads (Pharmacia). The final preparation was
dialyzed against 5 mM Hepes pH 7.6, 1 mM EDTA, 1 mM
DTT, 0.2 mM PMSF, 10% (v/v) glycerol (Ali and Siddiqui,
1995). GST and GST-La proteins were also purified by a
similar procedure. The (His)6-tagged HCV NS5B was
expressed in E. coli (BL21) and purified according to the
procedure described by Oh et al. (1999).
UV cross-linking of proteins with RNA
4-Thio-UDP (Sigma) was phosphorylated with nucleo-
side 5V-diphosphate kinase to prepare 4-thio-UTP (Ali andSiddiqui, 1995). The 3VNCR and ()5VNCR RNA probes
were synthesized in the presence of 4-thio-UTP and
[32P]CTP and extracted according to standard procedures.
The probes were mixed with purified HCV NS5B in RNA
binding buffer (5 mM HEPES [pH 7.6], 25 mM KCl, 2 mM
MgCl2, 1 mM EDTA, 1 mM DTT, 10% [v/v] glycerol) and
incubated at 30 -C for 30 min as described previously (Ali
and Siddiqui, 1995, 1997). For competition analysis,
increasing amounts of GST-PTB or GST were added along
with the components of the reaction mixture prior to UV
cross-linking. The UV cross-linking was carried out in
Stratalinker (Stratagen) for 30 min at 4 C. The ribonucleo-
protein complexes were treated with RNase A (10–20 U)
(USB) and analyzed by 12% SDS–PAGE followed by
autoradiography. The identity of cross-linked ribonucleo-
protein products (NS5B-RNA and PTB-RNA) was verified
by immunoprecipitation and by comparison of their relative
mobility in the same gel.
GST pull-down assay
The HCV NS5B was translated in rabbit reticulocyte
lysates (RRL) using in vitro transcribed EMCV-5B RNA
and the protein was radiolabeled with 35S-Methionine
according to the recommended protocol (Promega). The
protein synthesis was confirmed by SDS–PAGE and
autoradiography. GST, GST-PTB, or GST-La proteins were
immobilized on glutathione-Sepharose beads (Amersham).
The RRL containing labeled NS5B was diluted in 500 Al
buffer B (25 mM HEPES, pH 7.9, 150 mM KCl, 6 mM
MgCl2, 1 mM DTT, 0.1% NP-40, protease inhibitor
cocktail) and added to the beads. One of the samples was
treated with 10 Ag of RNase A to digest the template RNA.
The binding was carried out at 4 -C for 2 h. The unbound
materials were washed six times and the samples were
analyzed by SDS–PAGE followed by autoradiography.
Indirect immunofluorescence microscopy
Huh-7 cells were grown on glass cover slips and
transfected with in vitro transcribed BB7 or BB7 Pol
RNA. The cells were washed twice with PBS and fixed with
PBS containing 4% formaldehyde for 20 min at RT. After
washing the cells 4 times, the cells were permeabilized with
cold acetone for 7 min. The cover slips were washed and
treated with blocking buffer (10% fetal bovine serum, 0.1%
Triton X-100 in PBS buffer) for 1 h at RT. The polyclonal
anti-PTB antibodies and monoclonal anti-NS5B antibodies
were added to the cells and incubated for 1 h. The unbound
antibodies were washed and FITC and TRITC conjugated
secondary antibodies were added to detect NS5B and PTB,
respectively. The cover slips were mounted on the glass
slides in the presence of Slowfade Light Antifade (Molec-
ular Probes). The immunofluorescence was detected using a
Zeiss microscope (Axioplan2). In a similar experiment, the
pCMV/720–3010 DNA was transfected into Huh-7 cells
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Immunoprecipitation
HeLa S10 cytoplasmic fractions from suspension cul-
tures of HeLa S3 were prepared as described by Barton et al.
(1996). For immunoprecipitation and Western blot analysis,
the HCV NS proteins (NS3 through NS5B) were synthe-
sized in a reaction mixture containing 150 Al S10 lysates, 60
Al IF (initiation factors) lysates, 20 Al ATP generating
system, 5 Al RNasin, and 16 Ag BB7 RNA in a total volume
of 300 Al. The translation was carried out at 30 -C for 2 h
followed by treatment with RNase A/RnaseT1 mixture
(Ambion) for 30 min. Two hundred microliters of NETS
buffer (50 mM Tris–HCl, [pH 7.4], 5 mM EDTA, 1 mM
DTT, 100 mM NaCl, 0.05% Nonidet P-40) was added to an
aliquot of 50 Al translation mix and the immunoprecipitation
was carried out with antibodies against NS3 and NS5B.
Normal human IgG served as control. The immunocom-
plexes were immobilized on Protein G-Sepharose 4B beads
for 2 h at 4 C. The unbound materials were washed six times
with the NETS buffer. The bound proteins were fractionated
by SDS–PAGE and subjected to a Western blot analysis
using a monoclonal anti-PTB antibody (7G12). The blot
was developed using ECL techniques (Amersham Pharma-
cia Biotech).
The cell-free replication lysates derived from the FCA4
cell line were prepared as described previously (Ali et al.,
2002). This cell line is derived from Huh-7 cells selected in
the presence of G418 after RNA transfection with sub-
genomic HCV replicon. These cells stably express the HCV
replicon at a high efficiency and contain adaptive mutations
(Guo et al., 2001). These lysates were treated with RNase A/
T1 mix (20 Ag) and subjected to immunoprecipitation and
Western blot analysis as described above. The Huh-7 lysates
that were prepared similarly were used as a control.Acknowledgments
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